Skip to content

Evaluation of Caries Prevention Based on Genetic Etiology and Risk.

Evaluation of Caries Prevention Based on Genetic Etiology and Risk: Protocol for a Multicenter Randomized Controlled and Adaptive Trial for Oral Personalized Care (PRECARIES)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05600517
Acronym
PRECARIES
Enrollment
520
Registered
2022-10-31
Start date
2021-08-25
Completion date
2025-12-31
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries,Dental

Keywords

caries, genetic, prevention, saliva, S. Mutans, lifestyle, microbiota, exposure, Proline rich protein gene 1 (PRH1), Proline rich protein gene 2 (PRH2), Deleted malignant brain tumour (DMBT-1)

Brief summary

Dental caries affects billions of people worldwide and involves saliva immunodeficiency, commensal pathogen and exposure (lifestyle) causal subtypes of the disease. Up to 85% of adolescents in Swedish and other low prevalence populations are caries-free while the remaining 15% show high, recurrent caries activity. Accordingly, there is a lack of cost-effective risk assessment and prevention tools for personalized oral care. This randomized adaptive clinical trial (RCT) evaluates both caries prevention based on genetic etiology and risk, as a consequence of saliva immunodeficiency genes specifying individuals as susceptible or resistant to caries, and the effect of intensified versus selfcare traditional prevention on the two groups.

Detailed description

This is a protocol for a multicenter risk assessment and intervention study (PRECARIES) with an adaptive component. The study design comprises a prescreen of 2000 adolescents of which 520 will be included in the RCT study part with adolescents undergoing ordinary orthodontic treatment with multibrackets at the Public Dental Service. The orthodontic treatment allows for rapid caries development and improved discrimination between susceptible versus resistant individuals. The children are genotyped into two risk groups; genetic susceptible and non-susceptible children that are assigned to intensive or traditional standard prevention. The clinical outcomes will adaptively be measured at different time points (0, 6, 12 and months) as caries lesions at different teeth and surfaces using tactile, visual and X-ray bitewing, clinical photos and quantitative laser fluorescence (QLF). Secondary outcomes will be inflammation at the gingival margins and pocket depth at debonding of the orthodontic appliances. Questionaires are collected as well as biological samples; swab-dna, whole and parotid saliva and microbiota. Human and microbiota geno-and protein typing involves in and ex house platforms adaptively.

Interventions

OTHERFluoride

a patient-centered education on diet, oral hygiene and fluoridated toothpaste 5000ppm with check up´s and topical fluoride application (varnish) every second month.

Sponsors

Vastra Gotaland Region
CollaboratorOTHER_GOV
Region Västerbotten
CollaboratorOTHER_GOV
Region Skane
CollaboratorOTHER
Region Halland
CollaboratorOTHER
Uppsala-Örebro Regional Research Council
CollaboratorOTHER
Region Östergötland
CollaboratorOTHER
Region Gävleborg
CollaboratorOTHER
County Council of Norrbotten, Sweden
CollaboratorOTHER_GOV
Västernorrland County Council, Sweden
CollaboratorOTHER_GOV
The Swedish Research Council
CollaboratorOTHER_GOV
Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Participant is not informed about if they are in the control or intervention group Outcome assessor are not aware of group allocation Both dentist/nurse and patient do not know the genotype or risk group. Caries registration at start and end will be performed by a dentist not involved in giving the orthodontic treatment or prevention to each patient

Intervention model description

Randomized controlled study

Eligibility

Sex/Gender
ALL
Age
13 Years to 23 Years
Healthy volunteers
No

Inclusion criteria

\- undergoing orthodontic treatment with fixed multibrackets appliance in the upper and lower arch

Exclusion criteria

* impacted canines * agenesis in the frontal region * maxillofacial surgery

Design outcomes

Primary

MeasureTime frameDescription
% change in increment DeFS (decayed, enamel included and filled tooth surfaces)6 monthsThe % change in ΔDeFS caries increment over a follow up period of 6 and 24 months related to prevention.
DFS (decayed and filled tooth surfaces) and DeFS (decayed, enamel included and filled tooth surfaces)Baseline (0 months)The baseline and prospective caries scores for incidence and progression of lesions related to risk group

Secondary

MeasureTime frameDescription
Gingival inflammationBaseline (0 months)Bleeding on probing quadrant 3, Gingival inflammation will be represented by the index Bleeding on probing (BoP). BoP will be performed at the buccal surfaces in the third quadrant of the mouth approximately 21 surfaces
Mineralization disordersBaseline (0 months)Mineralization disturbances in enamel, including fluorosis, molar-incisor-hypo-mineralization, amelogenesis imperfecta are noted in the clinical examinations and by viewing clinical photographs and QLF technique.

Other

MeasureTime frameDescription
Life style variablesBaseline (0 months)Sociodemographic data (sex and ethnicity), oral hygiene, intake frequency of sweets (e.g., cookies, biscuits, ice cream or dried fruit) and sugary drinks (never, once per month, once per week, several times per week, once per day, several times per day), and the use of extra fluoride
MicrobiotaBaseline (0 months)Number and type of S. mutans

Countries

Sweden

Contacts

Primary ContactNicklas Strömberg, Prof
nicklas.stromberg@umu.se+46733544395
Backup ContactAnna Westerlund, Ass Prof
anna.westerlund@odontologi.gu.se+46703171213

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026